AR-Aid Patient Management Tool
In the clinical trial,
Noninfectious leukocytosis reported in patients with R/R AML
All grades |
≥Grade 3 |
---|---|
26 (12) |
12 (6) |
ADDITIONAL ANALYSIS: Frequency of NONINFECTIOUS LEUKOCYTOSIS over time1
Download our IDHIFA® wallet cards, printable cards for patients and caregivers to show to their non-regular healthcare providers. These printable resources also include information about differentiation syndrome and other ARs associated with IDHIFA®.
IDHIFA® Wallet Cards
For noninfectious leukocytosis (white blood cell [WBC] count is greater than 30x109/L)
Download our IDHIFA® wallet cards, printable cards for patients and caregivers to show to their non-regular healthcare providers. These printable resources also include information about differentiation syndrome and other ARs associated with IDHIFA®.
IDHIFA® Wallet Cards
Eligibility
Patients must meet the following criteria to enroll:
Program Benefits
Program Timing
Additional Terms and Conditions of the Celgene Commercial Co-pay Programs
© 2017 Celgene Corporation 06/17 US-CELG170216
This site is intended for U.S. audiences only.